Dr Javier de Castro, president of the Spanish Society of Medical Oncology, warned that cancer patients in Spain face severe financial toxicity from unfunded treatments. Surmounting the disease no longer depends solely on medical care, as many patients encounter a second economic struggle during or after therapy.
Expenses such as skin creams, post-surgical physiotherapy, nutritional supplements, laxatives, travel, home adaptations, and lost working hours represent hidden costs for families. De Castro explained that financial toxicity occurs when patients must pay out of pocket for side effects and secondary care not covered by the public healthcare system.
Modern oncology advances allow more individuals to survive for longer periods while receiving extended treatments. However, De Castro stated that higher survival rates and prolonged therapies increase the financial burden of complementary care, affecting millions of cancer survivors across Spain.
Unfunded medical supplies
The financial pressure extends well beyond prescription medicine into parapharmacy and complementary care. Dermatological items to relieve treatment side effects, specialized shampoos, wigs, adapted diets, and nutritional supplements fall outside the public healthcare funding portfolio.
Common side effects like constipation present unexpected costs because laxatives are not funded by public health. De Castro noted that while individual expenses appear small, they accumulate into a major monthly burden for households managing long term care.
Survival is no longer evaluated solely by the absence of a tumor, but also by personal autonomy, economic stability, and the ability to return to work. Financial strain prevents many patients from recovering their quality of life after finishing active medical treatment.
Vulnerable patient groups
Financial toxicity affects patients unevenly across different demographic groups. De Castro highlighted that low income pensioners face severe difficulty when spending nearly 10 percent of a 600 or 700 euro monthly pension on creams, laxatives, and personal care supplies.
Self-employed workers experience acute hardship compared to salaried employees who receive broader coverage during temporary disability. De Castro noted that many self-employed individuals continue working beyond recommended limits because they must keep businesses open or maintain family income.
Alfonso Aguaron, director of patient participation at the Patvocates Association, stated that vulnerability rises from combined income losses and increased spending. He identified high risk groups including young working age patients, single parent families, low income workers, people in precarious jobs, patients living far from hospitals, and elderly individuals with limited support networks.
Caregivers also face substantial financial pressure. Aguaron noted that family members frequently experience reduced earning capacity after taking on new responsibilities to assist patients through daily care and hospital visits.
Survey on economic losses
Data from a report by the Spanish Association Against Cancer illustrates the scale of financial disruption. The survey revealed that 56.9 percent of cancer patients lost income due to the disease, while 28.5 percent had to alter or leave their employment.
The report showed that 22 percent of caregivers suffered an income reduction, and 7 percent stopped working entirely to care for a relative. Social inequalities further compound the strain, as 72 percent of lower social class individuals reported they could not afford to lose work days, compared to 34 percent among wealthier classes.
Indirect costs add up quickly over extended treatment periods. Aguaron pointed out that routine expenses like 10 euros for parking, 30 euros for fuel, or meals away from home become significant when repeated for months, alongside costs for lodging, psychological support, and home assistance.
Prior financial standing heavily influences patient outcomes and adaptation. Living alone differs sharply from having a strong family network, just as residing in an accessible building differs from living without a lift when mobility problems arise.
Clinical response and policy reforms
Oncologists in Spain are increasingly integrating social environment evaluations into clinical consultations. De Castro explained that discussions about employment, family support, and financial hardship arise naturally when patients report an inability to afford necessary items.
Public health administrations face challenges in meeting these growing needs amidst population ageing and rising cancer survival. De Castro stated that addressing financial disruption is a key element of patient centered care that requires systemic updates.
The Spanish Society of Medical Oncology is developing programs focused on cancer related disabilities, social health factors, and oncologist training. The organization also advocates for supervised physical exercise, which has proven benefits but remains dependent on personal financial means.
De Castro emphasized that facilitating a gradual return to work is essential for long term economic protection. He concluded that treatment success should be measured not only by survival years, but by restoring a life project without permanent economic damage.
A decade of out of pocket costs
Inma Escriche, who was diagnosed with lung cancer ten years ago, shared her experience managing continuous out of pocket expenses. She explained that patients initially pay for necessary items without hesitation, even as medical leave reduces overall household income.
Escriche had to purchase an articulated bed and a reclining armchair to maintain daily comfort. Unfunded medications needed to mitigate chemotherapy and radiotherapy side effects included stomach protectors, eye drops, special nail varnishes, and dental treatments for mouth sores and loose teeth.
Home modifications accumulated over time, including replacing a bathtub with a shower, mounting bathroom grab bars, buying bed protectors, and purchasing headscarves or wigs. As mobility declined, Escriche purchased a wheelchair and ultimately a walker.
Escriche admitted that looking back, she avoids calculating the total amount spent along the way. She noted that these expenditures were not spent to cure the disease, but simply to achieve basic standards of daily quality of life.
